Opendata, web and dolomites

INHIBITHUMAN SIGNED

Dis-inhibitory circuits in the human cerebral cortex

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 INHIBITHUMAN project word cloud

Explore the words cloud of the INHIBITHUMAN project. It provides you a very rough idea of what is the project "INHIBITHUMAN" about.

compartment    intracortical    regulators    imaging    cell    resolution    redistribution    neuropeptides    substrates    glutamatergic    modulating    molecule    specialised    generate    controls    cortical    cellular    cognitive    ordination    endocannabinoids    alteration    monoamines    plastic    receptors    interventions    underlies    therapeutic    cerebral    interneurons    influences    output    molecular    drugs    elucidate    altering    cns    sites    receptor    strategies    neurons    subcellular    pharmacological    gated    action    neuronal    cortex    occurs    plasticity    neuron    combined    gabaergic    localisation    act    mechanisms    cells    mediated    electrophysiology    governed    enhancers    mammals    small    firing    temporal    co    windows    types    human    circuits    first    ach    inhibitory    physiological    overarching    dynamics    hypotheses    pyramidal    neuropharmacology    integration    dis    dependent    synaptic    events    connections    unprecedented    operations    mglurs    inhibition    inhibit    modulation    characterise   

Project "INHIBITHUMAN" data sheet

The following table provides information about the project.

Coordinator
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD 

Organization address
address: WELLINGTON SQUARE UNIVERSITY OFFICES
city: OXFORD
postcode: OX1 2JD
website: www.ox.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Total cost 2˙499˙913 €
 EC max contribution 2˙499˙913 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2015-AdG
 Funding Scheme ERC-ADG
 Starting year 2016
 Duration (year-month-day) from 2016-12-01   to  2021-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD UK (OXFORD) coordinator 1˙796˙038.00
2    AARHUS UNIVERSITET DK (AARHUS C) participant 703˙875.00

Map

 Project objective

Temporal co-ordination of the activity of cortical neurons underlies cognitive processes. Intracortical inhibitory circuits set temporal windows for modulation of glutamatergic pyramidal cell firing. In non-human mammals, the activity of the GABAergic neurons is governed by other specialised GABAergic neurons, which can dis-inhibit pyramidal cells. The overarching aim of this project is to define cellular and pharmacological mechanisms of dis-inhibitory circuits in the human cerebral cortex. These circuits could act as regulators of cognitive process. First, we will investigate the neuron types and their synaptic influences to characterise how dis-inhibition controls synaptic integration and the output of neurons. Second, we will elucidate synaptic plasticity in dis-inhibitory circuits, as plastic events likely represent physiological substrates of cognitive operations. Third, we will identify the subcellular sites and the mechanisms of action of key receptors for ACh, monoamines, endocannabinoids, neuropeptides and mGluRs modulating dis-inhibitory circuits, which are targets of small molecule CNS drugs, such as cognitive enhancers. We will test three hypotheses: 1) the human cortical pyramidal cell output is gated by compartment-specific dis-inhibition mediated by specific interneurons; 2) activity-dependent plasticity occurs in dis-inhibitory circuits and has consequences for the output of cortical pyramidal neurons; 3) small molecule drugs act via dis-inhibitory mechanisms at cell-type specific sites altering the inhibitory dynamics of pyramidal cells leading to subcellular redistribution of inhibition and alteration in their output. Combined electrophysiology/imaging with neuropharmacology and high resolution molecular receptor localisation will generate an unprecedented knowledge of the human cortical circuits. Understanding human cortical neuronal connections and their responses to pharmacological interventions may also lead to novel therapeutic strategies.

 Publications

year authors and title journal last update
List of publications.
2019 Marco Bocchio, Istvan P. Lukacs, Richard Stacey, Puneet Plaha, Vasileios Apostolopoulos, Laurent Livermore, Arjune Sen, Olaf Ansorge, Martin J. Gillies, Peter Somogyi, Marco Capogna
Group II Metabotropic Glutamate Receptors Mediate Presynaptic Inhibition of Excitatory Transmission in Pyramidal Neurons of the Human Cerebral Cortex
published pages: , ISSN: 1662-5102, DOI: 10.3389/fncel.2018.00508
Frontiers in Cellular Neuroscience 12 2019-08-29

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INHIBITHUMAN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "INHIBITHUMAN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

SoftHandler (2019)

Commercial feasibility of an integrated soft robotic system for industrial handling

Read More  

HyperCube (2020)

HyperCube: Gram scale production of ferrite nanocubes and thermo-responsive polymer coated nanocubes for medical applications and further exploitation in other hyperthermia fields

Read More  

THERMONANO (2018)

Nanoassemblies for the subcutaneous self-administration of anticancer drugs

Read More